Metronidazol Noridem

Metronidazole, the active ingredient in Metronidazol Noridem, is a Nitroimidazole presented as an injectable solution for intravenous use. It is employed to treat a range of anaerobic bacterial and protozoal infections in both adult and pediatric patients when prescribed by a qualified health professional under medical supervision.

GNH USA supplies Metronidazol Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution, ensuring product integrity throughout the supply chain.

Metronidazole is an antimicrobial agent used to treat infections caused by anaerobic bacteria and certain protozoa. - Bacterial vaginosis: eliminates the anaerobic bacteria responsible for the condition, relieving discharge and odor. - Trichomoniasis: eradicates Trichomonas vaginalis, reducing symptoms and preventing transmission. - Amoebiasis: clears intestinal Entamoeba histolytica infection, alleviating dysentery and liver involvement. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding resolution of severe colitis. - Anaerobic bacterial infections: targets a broad spectrum of anaerobes in intra‑abdominal, pelvic and soft‑tissue infections.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild headache. - Diarrhea: loose stools. - Abdominal pain: crampy discomfort. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Stevens‑Johnson syndrome: severe skin blistering. - Hepatotoxicity: elevated liver enzymes or liver injury. - Neutropenia: marked reduction in white blood cells.

Before using Metronidazol Noridem, consider the following precautions to ensure safe administration. - Renal impairment: assess kidney function and adjust therapy if necessary. - Hepatic dysfunction: monitor liver enzymes during treatment. - Alcohol consumption: avoid alcohol to prevent a disulfiram‑like reaction. - Pregnancy: use only when the potential benefit outweighs the risk. - Warfarin co‑therapy: monitor INR closely for increased anticoagulant effect. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metronidazol Noridem can interact with several medicines; categorize them by clinical significance.

Major Interactions (Avoid): - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium levels, leading to toxicity. - Alcohol: produces a disulfiram‑like reaction with flushing and nausea.

Moderate Interactions (Monitor Closely): - Phenobarbital: induces metabolism, reducing metronidazole concentrations. - Cimetidine: inhibits metabolism, raising metronidazole levels. - Phenytoin: decreases metronidazole efficacy through increased clearance.